Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07593404
NA

Evaluation of a Novel Ocular Lubricating Eye Drop

Sponsor: Pleryon Therapeutics (Hangzhou) Limited

View on ClinicalTrials.gov

Summary

The objective of this 2-part study is to assess the safety and tolerability of the new ocular lubricating drop ABR2 during short-term use in subjects for the temporary relief of ocular discomfort due to dryness of the eye. In Part 1, participant will receive 1 drop of ABR2 in one eye and through assessments over a 1-hour period. In Part 2, participant will use 1 drop of ABR2 at least two times a day for 28-day period (may use up to 4 times a day as needed) This is a single arm, open label study with no placebo or comparative arm.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-05

Completion Date

2027-05

Last Updated

2026-05-19

Healthy Volunteers

No

Interventions

DRUG

Part 2 ABR2 At least twice a day for 28 days

Use ABR2 at least BID, up to QID for 28 days

DRUG

Part 1: ABR2 single dose in one eye

Receive a single dose in one eye only

Locations (1)

Centre for Ocular Research & Education, School of Optometry & Vision Science, University of Waterloo

Waterloo, Ontario, Canada